National Cancer Institute

1

Minority Institutions/Cancer Center
Partnership Workshop November 20, 2003 Barbara
Fisher and Brian Martin

2
TOPICS TO BE DISCUSSED

• NCI GRANTS ADMINISTRATION BRANCH
• NEW/COMPETING APPLICATIONS
• PROGRESS REPORT/NONCOMPETING POST AWARD
  ADMINISTRATION
• GRANT CLOSEOUT

3
HANDOUTS

• SLIDE PRESENTATION
• BOOK Every Thing You Wanted to Know About The
  NCI Grants Process but Were Afraid to Ask
  http//www3.cancer.gov/admin/gab/index.htm

4
WEBSITE

• NIH Regional Seminars on Program and Grants
  Administration May June 2004
• http//grants.nih.gov/grants/seminars.htm

5

• GRANTS ADMINISTRATION BRANCH (GAB)

6

• NCI GRANTS ADMINISTRATION BRANCH (GAB)
• The GAB provides support for grants and
  cooperative agreements. NCI contracts are
  handled by the NCI Research Contracts Branch.
• The GAB consists of approximately 58 government
  employees and 16 contracted employees.
• The contracted employees manage the storage
  of grant files, records management, and
  electronic imaging.
• In Fiscal Year 2003, over 11,000 total grant
  actions were completed (competing, continuation
  grants, revisions and supplements). Within this
  number is approximately 7,400 initial grant
  actions awards

7
GAB TEAM CONCEPT

• The GAB is divided into 2 teams
• Biology and Population Sciences Grants Section
• Treatment, Diagnosis and Prevention Grants
• Section
• The two teams are divided into 4 sections
• Each Section has approximately 8 to 10 grant
  specialists

8
Biology and Population Sciences Grants Section

• TEAM 1
• Earl Bowman
• Funmi Elesinmogun
• Kimery Griffin
• Kent Hevner
• Lan Hoang
• Joy Kearse
• Amy Knight
• Sara Maclay
• Lisa Miller
• Marie Moyer
• Dena Solomon

• TEAM 2
• Catherine Blount
• Jennifer Edwards
• Priscilla Grant
• Galen Gregor
• Sean Hine
• Brian Iglesias
• Jennifer Nuchereno
• Teresa Parker
• Aida Vasquez
• Robynne Williams

9
Treatment, Diagnosis and Prevention Grants Section

• TEAM 3
• Victoria Bishton
• Rebecca Brightful
• Amy Connolly
• Cynthia Dwyer
• Barbara Fisher
• Connie Murphy
• Jill Rogers
• Judy Sint
• Ted Williams
• April Winegar

• TEAM 4
• Karen Chuang
• Kathy Dunn
• Debbie Dunne
• Barbara Liesenfeld
• Emily Linde
• Brian Martin
• Carol Perry
• Romy Reis
• Harry Seidman
• Shane Woodward

10

• The Partnership grants belong in the Treatment,
  Diagnosis and Prevention Grants Section
• Grants are assigned to specialists by
  institution. One institution could be handled by
  4 different grant specialists. GAB is striving
  to assign one specialist to a partnership.

11
ROLES AND RESPONSIBILITIES OF THE
GRANTS MANAGEMENT SPECIALIST

• Monitors administrative and fiscal aspects of
  grants and cooperative agreements
• Assures compliance with federal regulations,
  policies, and procedures
• Only NIH official authorized to change funding,
  duration and terms of award
• Issues Notice of Grant Awards
• Grants Management Specialist vs. Program Director

12
New/Competing ApplicationsType 1

• Brian Martin
• NCI Grants Administration Branch

13
Types of Minority Institution/Cancer Center
Partnerships

• U56 -- Cooperative Planning Grant for
  Comprehensive Minority Institution/Cancer Center
  Partnership
• http//grants.nih.gov/grants/guide/rfa-files/RFA-
  CA-03-008.html
• U54 -- Comprehensive Minority Institution/Cancer
  Center Partnership
• http//grants.nih.gov/grants/guide/rfa-files/RFA-
  CA-03-010.html
• P20 -- Planning Grant for Minority
  Institution/Cancer Center Collaboration
• http//grants1.nih.gov/grants/guide/rfa-files/RFA
  -CA-03-009.html

14
U56

• Application for the planning and development of
  Comprehensive Minority Institutions/Cancer Center
  Partnerships between Minority-Serving
  Institutions (MSI) and NCI-designated Cancer
  Centers.

15
U54

• Application for the implementation of
  Comprehensive Minority Institution/Cancer Center
  Partnerships between Minority-Serving
  Institutions (MSIs) and NCI-designated Cancer
  Centers in order to develop a stronger national
  cancer program aimed at understanding the reasons
  behind the significant cancer disparities and
  impact on minority populations.

16
P20

• Application to assist researchers and faculty in
  Minority Serving Institutions (MSIs) in
  collaboration with the researchers and faculty of
  NCI-designated Cancer Centers to plan and
  implement focused collaborations in cancer
  research, cancer research training and career
  development or cancer education.

17
U56 RFA Guidelines

• ALLOWABLE COSTS
• Administrative Costs Not to exceed 20 of the
  total direct costs per year per partner.
• Planning and Evaluation
• Developmental Costs
• Pilot cancer research projects or pilot cancer
  training and career development,
• Cancer education and/or cancer outreach program
  not to exceed 100,000
• in direct costs per year per project/program of
  the partnership for no more than
• three years.
• Resources and Infrastructure
• Start-up Packages

18
U56 RFA Guidelines

• The maximum combined direct cost budget of the
  MSI and the Cancer Center together is 500,000.
  Third party sub-contractual facilities and
  administration costs will not be counted toward
  the maximum combined direct costs of 500,000.
• The total project period will not exceed five
  years.

19
U54 Guidelines

• ALLOWABLE COSTS
• Administrative Costs Not to exceed 20 of the
  total direct costs per year per partner.
• Planning and Evaluation
• Developmental Costs
• Pilot cancer research projects or pilot cancer
  training and career development, cancer education
  and/or cancer outreach program not to exceed
  100,000 in direct costs per year per
  project/program of the partnership for no more
  than three years.

20
U54 Guidelines

• ALLOWABLE COSTS(cont.)
• Up to three full projects/programs per year may
  be funded (not to exceed 250,000 in direct costs
  per year per project/program of the partnership
  of no longer than three years).
• Resources and Infrastructure
• Start-up Packages

21
U54 Guidelines

• The maximum combined direct cost budget of the
  MSI and the Cancer Center together is 1.5
  million. Third party sub-contractual facilities
  and administration costs will not be counted
  toward the maximum combined direct costs of 1.5
  million.
• The total project period will not exceed five
  years.

22
P20 RFA Guidelines

• ALLOWABLE COSTS
• Administrative Costs
• Developmental Costs
• Initial Planning Stage
• Priority Setting Stage
• Implementation Stage

23
P20 RFA Guidelines

• The total annual direct cost budgets for the MSI
  and the Cancer Center applications together are
  expected to range between 50,000 and 250,000
  each year depending upon prior progress in
  planning and setting priorities.
• Third party contractual Facilities and
  Administrative costs will not be counted toward
  the maximum combined direct costs of 250,000.
• The total project period will not exceed three
• years.

24
PHS 398 APPLICATION

• The PHS 398 is required for all new, revised,
  competing continuation, and supplemental research
  grant, research training grant, and cooperative
  agreement applications.
• The PHS 398 can be found at
• http//grants1.nih.gov/grants/funding/phs398/phs39
  8.html

25
PHS 398 APPLICATION

• Budgets for these partnerships should not be
  prepared in modular format.
• Pay particular attention to the instructions for
  human and animals in the PHS 398. Be sure to
  address specific points.

26
IMPORTANT ISSUES FOR ALL APPLICATIONS

• Review and read entire RFA.
• Prepare application following instructions in PHS
  398 and Supplemental Instructions in RFA.
• Pay particular attention to SPECIAL
  REQUIREMENTS section of RFA.
• Pay particular attention to SUPPLEMENTAL
  INSTRUCTIONS section of RFA.
• WORK WITH AND CONSULT WITH THE CANCER CENTER
  PARTNER WHEN DEVELOPING BUDGETS, THEY HAVE THE
  EXPERIENCE.

27
NOTICE OF GRANT AWARD(NGA)

• Request a copy of the NGA from your Sponsored
  Programs Office.
• Read the NGA, it contains a lot of important
  information
• Become familiar with the NIH Grants Policy
  Statement.

28
NON-COMPETING GRANT PROGRESS REPORT(Type
5)Brian and Barbara
29
PHS 2590 APPLICATION

• An annual application must be submitted by the
  grantee to continue funding after the first year
  of a new award.
• Annual application submitted on a PHS 2590
• In conjunction with the standard instructions of
  the PHS 2590, the MI/CCP supplemental application
  guidelines must be addressed in the application.
• http//minority opportunities.nci.nih.gov/institu
  tions/dochtmls/comprehensive.pdf

30
PHS 2590 APPLICATION

• Application submission is due 60 days prior to
  the start date of the grant. This is determined
  by reading the Notice of Grant Award budget
  period end date. This is also published on the
  NIH Commons website listed at
• http//commons.era.nih.gov/commons/
• Non Streamlined-Non Competing Application
  Process(SNAP) MI/CCP grants require full
  categorical budgets with justification.
• Use Section B. under PREPARING YOUR PROGRESS
  REPORT, B. SPECIFIC INSTRUCTIONS, section 2.
  Detailed Budget for Next Budget Period.

31
PHS 2590 APPLICATION

• The Notice of Grant Award includes the total cost
  award level for each year. This level is
  established at the time of the competing year and
  will usually remain constant for the project
  period.
• Provide justification for the line items and
  amounts that represent a significant change from
  that previously recommended.

32
PHS 2590 APPLICATION

• Page 3 under CURRENT BUDGET PERIOD, state the
  estimated total costs remaining in the grant that
  are greater than 25 of the current years (last
  funded year) total authorization. (if applicable)
  
• If greater than 25, explain why there is the
  significant balance and how it will be spent if
  carried forward into the next budget period.
• If the PI intends to carryover unobligated funds,
  an official request must be submitted by the
  grantee authorized business official, to the
  grants management specialist noted on the last
  Notice of Grant Award.

33
PHS 2590 APPLICATION

• Other Support required only for active support
  of all key personnel.
• Progress Report Summary
• Enrollment Table only if conducting clinical
  research.
• Checklist

34

• EXPANDED AUTHORITIES

35

• NIH Grants Policy Statement (Rev. 03/01),
  Administrative Requirements Section
• Applies to all grants and cooperative agreement
  awards issued after 10/01/2001
• http//grants2.nih.gov/grants/guide/guide/noti
  ce-files/NOT-OD-01-070.HTML
• No rebudgeting of funds between the Partnership
  grants after the awards are issued.
• NIH Prior approval requirements listed below from
  the NIH Grants Policy Statement.

36
TABLE II-2SUMMARY OF ACTIONS REQUIRING NIH PRIOR
APPROVAL(Note The following table has been
revised in accordance with the 03/20/2001 NIH
Guide Notice)
37
(No Transcript)
38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41

• REBUDGETING between partnership grants, unique
  procedure prior to submission of Type 5
  application.
• FINANCIAL STATUS REPORT (FSR)
• Submitted on PHS 269 form
• 90 days after expiration date of the budget
  period end date

42
CARRYOVER

• CARRYOVER After FSR is submitted and accepted by
  NIH. The carryover request should be submitted
  on Institutional letterhead that includes
• Scientific justification
• Categorical budget and justification
• for intended use of these funds
• Carryover funds may not be rebudgeted between
  Partnership grants.

43
FINAL REPORTING REQUIREMENTS
44

• When a grantee accepts an award, the grantee also
  accepts responsibility for monitoring and
  reporting requirements.
• The PI and grantee organization is responsible
  for the submission of the
• 1. Final Progress Report institutional
  letterhead
• 2. Final Invention Statement
• http//grants.nih.gov/grants/hhs568
  .pdf
• 3. Final Financial Status Report
• www.whitehouse.gov/omb.grants/sf269
  .pdf

45

• Final Reports are required 90 days after the
  expiration of the project period.
• Delinquency in providing this information in a
  timely manner could jeopardize future funding of
  the PI and the grantee organization.
• NIH Grants Policy Statement Administrative
  Requirements, Closeout

46
HELPFUL WEB SITES

• NIH Office Of Extramural Research
• http//grants.nih.gov/grants/oer.htm
• NIH Grants Policy Statement
• http//grants1.nih.gov/grants/policy/nihgps_2001
  
• PHS 2590 Application
• http//grants.nih.gov/grants/funding/2590/2590.h
  tm

47
HELPFUL WEB SITES

• Financial Status Report(FSR)
• www.whitehouse.gov/omb/grants/sf269.pdf
• NEW GRANTEE http//grants1.nih.gov/grants/fundi
  ng/welcomewagon.htm

48

• THE
• END